Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37606747)
Watch
English
Molecular predictive and prognostic markers in non-small-cell lung cancer.
scientific article published on October 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Molecular predictive and prognostic markers in non-small-cell lung cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
author
Thomas John
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
Ming-Sound Tsao
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
author name string
Linda E Coate
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
Frances A Shepherd
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
publication date
1 October 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
volume
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
page(s)
1001-1010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
cites work
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erlotinib in lung cancer - molecular and clinical predictors of outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erlotinib in previously treated non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the Dako EGFR pharmDx kit and Zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Understanding prognostic gene expression signatures in lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression profiling of non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genomic signatures to guide the use of chemotherapeutics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970155-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(09)70155-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
PubMed publication ID
19796752
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19796752
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19796752%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit